ATAD1 and malaria: Although not perfect, non-human primate malaria models for P. falciparum, in species such as Aotus monkeys, provide an alternative method of in vivo assessment of candidate malaria vaccine efficacy [34]–[36], especially where there is no orthologue in any rodent malaria parasite protein, as is the case for MSP-1 Block 2.